The JAK2/STAT3 signaling pathway is involved in the development of insulin resistance in patients with T2DM, and its abnormal activation may damage pancreatic beta cells to reduce insulin synthesis (Mashili et al., 2013; Bharadwaj et al., 2020). This evidence concerns the gene JAK2 and Insulin resistance.